P42 Budget Impact Analysis of Eculizumab Biosimilar for Treatment of Paroxysmal Nocturnal Hemoglobinuria from Public Hospital Perspective in 2023
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.068
https://www.valueinhealthjournal.com/article/S1098-3015(24)00183-9/fulltext
Title :
P42 Budget Impact Analysis of Eculizumab Biosimilar for Treatment of Paroxysmal Nocturnal Hemoglobinuria from Public Hospital Perspective in 2023
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00183-9&doi=10.1016/j.jval.2024.03.068
First page :
Section Title :
Open access? :
No
Section Order :
10009